Alkem Laboratories Limited
ALKEM
株式のランク
#2895
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
株価
$52.51
時価総額
$6.28B
変化（1日）
-4.86%
変化（1年）
-16.69%
国
IN
取引 Alkem Laboratories Limited (ALKEM)
カテゴリー
Healthcare
Alkem Laboratories Limited（ALKEM）の収益
Jun 2026 時点の収益 TTM: $1.66B
Alkem Laboratories Limited の最新の財務報告によると、現在の収益 (TTM) は $1.66B です。2025 年には $1.50B の収益があり、これは 2024 年の $1.49B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Alkem Laboratories Limited の収益履歴（2010 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.66B | 11.17% |
| 2025 | $1.50B | 0.36% |
| 2024 | $1.49B | 7.16% |
| 2023 | $1.39B | 0.53% |
| 2022 | $1.38B | 16.14% |
| 2021 | $1.19B | 9.65% |
| 2020 | $1.09B | 3.92% |
| 2019 | $1.05B | 8.08% |
| 2018 | $968.16M | 11.79% |
| 2017 | $866.05M | 17.92% |
| 2016 | $734.41M | 23.43% |
| 2015 | $595.01M | 15.94% |
| 2014 | $513.19M | 22.45% |
| 2013 | $419.09M | 10.73% |
| 2012 | $378.47M | 2.07% |
| 2011 | $370.79M | 23.92% |
| 2010 | $299.23M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 297.25% |
IN
|
